Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

This study has been completed.

Study NCT00024557 Information provided by Insys Therapeutics Inc

First Received: September 20, 2001 Last Updated: June 2, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2007
Primary Completion Date:	June 2006 (Final data collection date for primary outcome measure)